In the cohort study of 327,112 new insulin users from five European countries, we addressed the relationship between insulin use and cancer incidence of ten site-specific cancers and any cancer, when mitigating methodological shortcomings and biases involved in previous studies. The gene discussed is INS; the disease is cancer.